Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.1%

3 terminated out of 74 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

14%

10 trials in Phase 3/4

Results Transparency

13%

4 of 30 completed with results

Key Signals

4 with results91% success

Data Visualizations

Phase Distribution

50Total
Not Applicable (33)
P 1 (1)
P 2 (6)
P 3 (5)
P 4 (5)

Trial Status

Completed30
Unknown24
Recruiting13
Terminated3
Not Yet Recruiting2
Active Not Recruiting2

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 30 completed trials

Clinical Trials (74)

Showing 20 of 20 trials
NCT03631173Not ApplicableActive Not Recruiting

Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy

NCT06743516Not ApplicableRecruitingPrimary

External Pancreatic Stent in Pancreaticojejunostomy

NCT07144917Recruiting

Immunoparalysis After Pancreaticoduodenectomy

NCT07479784Phase 3Not Yet RecruitingPrimary

Octreotide Microspheres for Preventing Pancreatic Fistula

NCT06756074Phase 2RecruitingPrimary

Reinforced Pancreaticojejunostomy With or Without glubran2

NCT02784990CompletedPrimary

Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions

NCT07370987Phase 2RecruitingPrimary

Prevention of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy by Preoperative Radiotherapy : a Phase 2 Trial

NCT07139236Recruiting

Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD

NCT07009119Not ApplicableRecruiting

Laparoscopic Pancreaticoduodenectomy

NCT05737875CompletedPrimary

Distal Pancreatectomy Pancreatic Fistula Risk Prediction Model Validation Study

NCT07022015Not ApplicableRecruiting

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

NCT06706440Completed

The Study of the Natural Way of Development of External Pancreatic Fistulas in Children with Necrotizing Pancreatitis

NCT06283160RecruitingPrimary

METabolomic and Immune PROfiling in the Development of Pancreatic Fistulas After cepHalic duodEnopancreatectomy

NCT05753735Phase 2TerminatedPrimary

eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF

NCT06198400Not ApplicableRecruitingPrimary

Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion.

NCT05017207CompletedPrimary

Clinically Relevant Pancreatic Fistula After Pancreaticoduodenectomy

NCT04985071Completed

Complication of Pancreatic Fistula and Bleeding After Pancreaticoduodenectomy in Treatment Periampullary Cancer

NCT05404256Not ApplicableRecruitingPrimary

Comparison of Effectiveness of TissuePatchTM in Preventing Postoperative Pancreatic Fistula

NCT04609137Not ApplicableCompleted

Early Drain Removal Versus Standard Drain Management After Distal Pancreatectomy (Early-Dist)

NCT06135012Not ApplicableUnknownPrimary

Influence of Pancreatic Transection With CUSA on Postoperative Pancreatic Fistula Incidence (PANCUT)

Scroll to load more

Research Network

Activity Timeline